Prurisol study randomized and underway 1 month ahe
Post# of 72430
![](/assets/46931549/no_avatar_available_thumb.jpg)
![:-) :-)](smileys/smile.gif)
News out.
Cellceutix Receives FDA Orphan Drug Designation for Kevetrin for the Treatment of Retinoblastoma
Company's Phase 2 Study of Plaque Psoriasis Completes Goal of Randomizing Subjects
http://finance.yahoo.com/news/cellceutix-rece...00762.html
Tic toc Leo, $5+ before the shareholder meeting.
![:-) :-)](smileys/smile.gif)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)